Oak Street Health, Inc. (NYSE:OSH) Expected to Announce Quarterly Sales of $519.41 Million

Equities analysts expect that Oak Street Health, Inc. (NYSE:OSHGet Rating) will report sales of $519.41 million for the current fiscal quarter, Zacks reports. Seven analysts have made estimates for Oak Street Health’s earnings, with the lowest sales estimate coming in at $513.80 million and the highest estimate coming in at $522.20 million. Oak Street Health reported sales of $353.10 million during the same quarter last year, which would suggest a positive year over year growth rate of 47.1%. The firm is scheduled to report its next earnings results on Monday, January 1st.

According to Zacks, analysts expect that Oak Street Health will report full year sales of $2.13 billion for the current year, with estimates ranging from $2.12 billion to $2.15 billion. For the next fiscal year, analysts expect that the firm will report sales of $2.99 billion, with estimates ranging from $2.63 billion to $3.16 billion. Zacks Investment Research’s sales calculations are an average based on a survey of research analysts that that provide coverage for Oak Street Health.

Oak Street Health (NYSE:OSHGet Rating) last announced its quarterly earnings results on Tuesday, May 3rd. The company reported ($0.43) EPS for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.04). Oak Street Health had a negative net margin of 26.82% and a negative return on equity of 413.94%. The company had revenue of $513.80 million during the quarter, compared to the consensus estimate of $506.82 million. During the same period last year, the company earned ($0.29) earnings per share. The business’s revenue was up 73.2% compared to the same quarter last year.

Several equities analysts have recently weighed in on OSH shares. Barclays increased their price objective on shares of Oak Street Health from $27.00 to $31.00 and gave the company an “overweight” rating in a research report on Tuesday, April 19th. UBS Group assumed coverage on Oak Street Health in a report on Wednesday, April 20th. They set a “neutral” rating and a $26.00 price target for the company. Canaccord Genuity Group cut their price objective on Oak Street Health from $49.00 to $29.00 in a report on Wednesday, March 2nd. Zacks Investment Research raised Oak Street Health from a “sell” rating to a “hold” rating in a report on Thursday. Finally, Morgan Stanley upped their target price on Oak Street Health from $18.00 to $19.00 and gave the company an “equal weight” rating in a research report on Wednesday, March 2nd. Five research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat.com, Oak Street Health currently has an average rating of “Buy” and an average price target of $39.79.

In related news, insider Geoffrey M. Price sold 80,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 22nd. The stock was sold at an average price of $24.83, for a total value of $1,986,400.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Geoffrey M. Price sold 60,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 5th. The stock was sold at an average price of $26.56, for a total transaction of $1,593,600.00. Following the transaction, the insider now owns 3,871,377 shares in the company, valued at $102,823,773.12. The disclosure for this sale can be found here. Insiders sold 275,000 shares of company stock valued at $6,529,450 over the last 90 days. Company insiders own 11.40% of the company’s stock.

Several large investors have recently modified their holdings of OSH. CI Investments Inc. acquired a new stake in Oak Street Health during the third quarter worth about $28,000. Confluence Wealth Services Inc. acquired a new stake in Oak Street Health in the fourth quarter worth about $34,000. Benjamin Edwards Inc. lifted its holdings in Oak Street Health by 9,016.7% in the first quarter. Benjamin Edwards Inc. now owns 1,094 shares of the company’s stock worth $29,000 after purchasing an additional 1,082 shares during the period. Canada Pension Plan Investment Board acquired a new stake in Oak Street Health in the 4th quarter valued at about $46,000. Finally, Fifth Third Bancorp acquired a new stake in Oak Street Health in the 1st quarter valued at about $46,000. Institutional investors and hedge funds own 91.42% of the company’s stock.

Shares of OSH opened at $17.92 on Friday. The stock has a market capitalization of $4.32 billion, a price-to-earnings ratio of -9.05 and a beta of 2.41. Oak Street Health has a 12 month low of $13.29 and a 12 month high of $65.22. The firm has a fifty day simple moving average of $22.07 and a 200 day simple moving average of $25.20. The company has a current ratio of 1.79, a quick ratio of 1.79 and a debt-to-equity ratio of 16.10.

Oak Street Health Company Profile (Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

Featured Articles

Get a free copy of the Zacks research report on Oak Street Health (OSH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.